TCT-728 The Impact of FDA Approval of Transcatheter Aortic Valve Replacement on the Treatment Assignment of Patients with Severe Aortic Stenosis

The number of Transcatheter Aortic Valve Replacement (TAVR) programs has increase in the US. However, the number of referrals to TAVR centers for evaluation remains uncertain. We sought to describe the temporal changes of treatment allocation after FDA approval of currently available transcatheter